- Home
- AKRO vs HTH Comparison
AKRO vs HTH Comparison
Compare AKRO & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- HTH
- Stock Information
- Founded
- AKRO 2017
- HTH 1998
- Country
- AKRO United States
- HTH United States
- Employees
- AKRO N/A
- HTH N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- HTH Major Banks
- Sector
- AKRO Health Care
- HTH Finance
- Exchange
- AKRO Nasdaq
- HTH Nasdaq
- Market Cap
- AKRO 3.9B
- HTH 1.9B
- IPO Year
- AKRO 2019
- HTH 2004
- Fundamental
- Price
- AKRO $51.41
- HTH $31.31
- Analyst Decision
- AKRO Strong Buy
- HTH Hold
- Analyst Count
- AKRO 6
- HTH 2
- Target Price
- AKRO $82.50
- HTH $33.00
- AVG Volume (30 Days)
- AKRO 1.8M
- HTH 424.2K
- Earning Date
- AKRO 08-08-2025
- HTH 07-24-2025
- Dividend Yield
- AKRO N/A
- HTH 2.30%
- EPS Growth
- AKRO N/A
- HTH 15.07
- EPS
- AKRO N/A
- HTH 1.97
- Revenue
- AKRO N/A
- HTH $1,208,822,000.00
- Revenue This Year
- AKRO N/A
- HTH N/A
- Revenue Next Year
- AKRO N/A
- HTH $1.36
- P/E Ratio
- AKRO N/A
- HTH $15.89
- Revenue Growth
- AKRO N/A
- HTH 2.13
- 52 Week Low
- AKRO $21.02
- HTH $26.67
- 52 Week High
- AKRO $58.40
- HTH $35.32
- Technical
- Relative Strength Index (RSI)
- AKRO 47.91
- HTH 64.74
- Support Level
- AKRO $53.05
- HTH $29.82
- Resistance Level
- AKRO $57.35
- HTH $30.54
- Average True Range (ATR)
- AKRO 2.45
- HTH 0.55
- MACD
- AKRO -0.64
- HTH 0.14
- Stochastic Oscillator
- AKRO 4.65
- HTH 90.19
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.